Drug Approval | July 04, 2022
OliX Pharmaceuticals submits application to U.S. FDA to evaluate safety and tolerability of OLX10212
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.